GANX
GANX
NASDAQ · Biotechnology

Gain Therapeutics Inc

$1.07
-0.01 (-0.93%)
As of Nov 13, 2:55 PM ET ·
GANX vs Biotechnology Average
Profit Margin
GANX -21.0%
Avg -192.1%
Rev Growth
GANX +22.4%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
GANX Gain Therapeutics Inc $1.07 -0.93% 44.95M — -21.0% +22.4% — Current
ABBV Abbvie Inc $295.03 +0.20% 520.47B 50.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $465.67 -0.30% 252.64B 26.9 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $168.08 +0.08% 208.95B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $538.60 -0.74% 134.82B 33.9 32.9% +10.4% — Strong buy Compare
MRNA Moderna Inc $223.37 -3.45% 105.54B — -145.2% -53.4% — Hold Compare
REGN Regeneron Pharmaceuticals $955.47 +0.45% 98.38B 20.4 31.4% +5.6% — Buy Compare
NTRA Natera Inc $319.09 -1.19% 45.18B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $172.29 -2.30% 41.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $253.40 +1.17% 36.60B 43.9 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $39.53 -1.15% 28.08B — -3,629.2% -48.7% — Strong buy Compare
UTHR United Therapeutics Corp $591.17 -0.36% 24.27B 18.5 41.9% +18.0% — Strong buy Compare
INCY Incyte Corp $120.97 -0.60% 24.22B 15.0 25.0% +14.8% — Hold Compare
INSM Insmed Inc $121.16 +2.62% 23.86B — -210.5% +35.2% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $165.04 +5.36% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
EXEL Exelixis Inc $69.00 -1.20% 16.67B 18.8 33.7% +12.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $167.40 -1.18% 16.41B 23.3 16.7% +24.3% — Strong buy Compare
BBIO Bridgebio Pharma Inc $78.30 +0.17% 14.51B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $100.27 -0.40% 13.96B 33.7 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $14.15 -6.14% 12.69B — 15.4% -3.6% — Buy Compare